Most of the 100 potential vaccines being investigated across the world use a cell line derived originally from a child aborted in Holland in 1973. Known as HEK293, it has also been used in cancer research and in developing commonly accepted vaccinations such as rubella, hepatitis A and rabies. By contrast, a smaller number of possible Covid vaccines, including the one at Imperial College, London, are synthetically derived.